PL2538918T3 - Cytocholina do leczenia jaskry - Google Patents
Cytocholina do leczenia jaskryInfo
- Publication number
- PL2538918T3 PL2538918T3 PL11711656T PL11711656T PL2538918T3 PL 2538918 T3 PL2538918 T3 PL 2538918T3 PL 11711656 T PL11711656 T PL 11711656T PL 11711656 T PL11711656 T PL 11711656T PL 2538918 T3 PL2538918 T3 PL 2538918T3
- Authority
- PL
- Poland
- Prior art keywords
- citicoline
- glaucoma
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM2010A000071A IT1398378B1 (it) | 2010-02-22 | 2010-02-22 | Citicolina per il trattamento del glaucoma e dell'ipertensione oculare. |
| PCT/IB2011/050663 WO2011101802A1 (en) | 2010-02-22 | 2011-02-17 | Citicoline for the treatment of glaucoma and ocular hypertension |
| EP11711656.6A EP2538918B1 (en) | 2010-02-22 | 2011-02-17 | Citicoline for the treatment of glaucoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2538918T3 true PL2538918T3 (pl) | 2015-05-29 |
Family
ID=42790833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11711656T PL2538918T3 (pl) | 2010-02-22 | 2011-02-17 | Cytocholina do leczenia jaskry |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8822429B2 (pl) |
| EP (1) | EP2538918B1 (pl) |
| JP (1) | JP5801324B2 (pl) |
| ES (1) | ES2528366T3 (pl) |
| IT (1) | IT1398378B1 (pl) |
| PL (1) | PL2538918T3 (pl) |
| WO (1) | WO2011101802A1 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20120284A1 (it) * | 2012-06-18 | 2013-12-19 | Omikron Italia S R L | Citicolina per il trattamento della retinopatia diabetica. |
| ITMI20121223A1 (it) * | 2012-07-13 | 2014-01-14 | Gregorio Fabio De | Nuova composizione farmacologica comprendente citicolina in combinazione con glicerolo e/o acetazolamide |
| EP2900680A4 (en) * | 2012-09-28 | 2016-06-08 | Univ Tufts | URIDEINDIPHOSPHATE DERIVATIVES, PRODRUGS, COMPOSITIONS AND USES THEREOF |
| KR102304242B1 (ko) | 2013-03-13 | 2021-09-17 | 터프츠 유니버시티 | 유리딘 뉴클레오사이드 유도체, 조성물 및 사용 방법 |
| ITUA20161679A1 (it) * | 2016-03-15 | 2017-09-15 | Neuraxpharm Italy S P A | Composizione per prevenire e trattare patologie neurodegenerative e disturbi cognitivi |
| IT201600103956A1 (it) * | 2016-10-17 | 2018-04-17 | Omikron Italia S R L | Formulazione oftalmica comprendente citicolina veicolata da liposomi per il trattamento del glaucoma |
| EP4356906A1 (en) * | 2022-10-20 | 2024-04-24 | SIFI S.p.A. | Composizione nutraceutica ad effetto neuroprotettivo per il trattamento del glaucoma |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9303627D0 (sv) * | 1993-11-03 | 1993-11-03 | Kabi Pharmacia Ab | Method and means for prevention of cataract |
-
2010
- 2010-02-22 IT ITRM2010A000071A patent/IT1398378B1/it active
-
2011
- 2011-02-17 JP JP2012553433A patent/JP5801324B2/ja active Active
- 2011-02-17 ES ES11711656.6T patent/ES2528366T3/es active Active
- 2011-02-17 EP EP11711656.6A patent/EP2538918B1/en active Active
- 2011-02-17 WO PCT/IB2011/050663 patent/WO2011101802A1/en active Application Filing
- 2011-02-17 US US13/580,181 patent/US8822429B2/en active Active
- 2011-02-17 PL PL11711656T patent/PL2538918T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8822429B2 (en) | 2014-09-02 |
| JP5801324B2 (ja) | 2015-10-28 |
| EP2538918B1 (en) | 2014-11-19 |
| WO2011101802A1 (en) | 2011-08-25 |
| JP2013520406A (ja) | 2013-06-06 |
| ITRM20100071A1 (it) | 2011-08-23 |
| IT1398378B1 (it) | 2013-02-22 |
| US20120316128A1 (en) | 2012-12-13 |
| EP2538918A1 (en) | 2013-01-02 |
| ES2528366T3 (es) | 2015-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1201042A1 (en) | Compositions for the treatment of dry eye | |
| HK1199099A1 (en) | Methods and compositions for the treatment and diagnosis of cancer | |
| HK1197400A1 (zh) | 治療 的化合物 | |
| ZA201403795B (en) | Formulations for the treatment of diabetes | |
| EP2621499A4 (en) | METHODS OF TREATING ALLERGIC DISEASES | |
| EP2654745A4 (en) | COMPOSITION FOR TREATING SKIN CONDITIONS OF THE SKIN | |
| EP2773342A4 (en) | COMPOSITIONS USEFUL FOR THE TREATMENT OF VIRAL DISEASES | |
| EP2723924A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF CANCER | |
| SG2014014724A (en) | METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS | |
| HK1185874A1 (zh) | 用於治療癌症的新的 -氨基- -羥基-苯甲酰胺 | |
| IL225896A0 (en) | Treatment of mecp-2 related disorders | |
| PL2538918T3 (pl) | Cytocholina do leczenia jaskry | |
| IL230960A0 (en) | A device for the treatment of eye disease | |
| IL231593B (en) | Buprenorphine for the treatment of acute suicidality | |
| IL275636A (en) | Medical combination for cancer treatment | |
| EP2536436A4 (en) | ANTIMIR-451 FOR THE TREATMENT OF POLYCYTHEMICS | |
| IL230959B (en) | A device for the treatment of eye disease | |
| PL2593423T3 (pl) | Proces wytwarzania środków kontrastowych | |
| HUP1100290A2 (en) | Combination compositions for the treatment of proliferative diseases | |
| ZA201400488B (en) | Compounds for the treatment of cancers associated with human papillomavirus | |
| IL234796B (en) | Compounds for the treatment of diseases related to ischemia-reperfusion | |
| PL2456445T3 (pl) | Środek do leczenia chorób skóry | |
| EP2696872A4 (en) | TREATMENT OF GLAUCOMA | |
| HK1196953A1 (zh) | 用於治療糖尿病的製劑 | |
| ZA201304121B (en) | Arlysulfonamide derivatives for the prevention or treatment of specific ophthalmologic disorders |